- Granted IMC-G.A.P. Equivalency Certification by Control Union (“CU”)
- Milestone to export to Israel and EU-GMP facilities in Europe and Australia
[PRESS RELEASE] – VANCOUVER, British Columbia, Feb. 11, 2025 – Rubicon Organics Inc., a licensed producer focused on cultivating and selling organic certified and premium cannabis products, announced that its Delta Facility has received its CUMCS Equivalency IMC-G.A.P. certification (the “certification”), the leading certification standard for medical cannabis cultivation, harvest, and primary processing.
“There is tremendous demand for Rubicon Organic’s premium and organic cannabis from the international medical markets, and we are ready to meet the rising demand for high-quality medical cannabis products with initial exports planned in 2025,” CEO Margaret Brodie said.
Through the IMC-G.A.P. certification process, CU has declared that Rubicon Organics’ dried cannabis products are compliant in accordance with the World Health Organization’s (WHO) guidelines on Good Agricultural Practices (GACP) Medicinal Plants, the European Medicines Agency’s (EMEA) guideline on GACP for starting materials of herbal origin, Dutch Office of Medicinal Cannabis' guidelines for cultivating cannabis for medicinal purposes, and GLOBALG.A.P.'s IFA 4.0 (FV), thus demonstrating equivalency to the Israeli Medical Cannabis Agency at the Ministry of Health (IMCA) Directive 151/2016 - IMC-GAP Certification.
Obtaining the certification provides documented evidence that Rubicon Organics has met strict international standards for quality and consistency in the cultivation, harvest and primary processing of cannabis needed for the export of cannabis inputs to certain jurisdictions, including Israel, Europe and Australia, for further processing into finished goods via a Good Manufacturing Practices (GMP) certified production facility.
